Literature DB >> 29744615

Systems Biology, Systems Medicine, Systems Pharmacology: The What and The Why.

Angélique Stéphanou1, Eric Fanchon2, Pasquale F Innominato3,4,5, Annabelle Ballesta4,5.   

Abstract

Systems biology is today such a widespread discipline that it becomes difficult to propose a clear definition of what it really is. For some, it remains restricted to the genomic field. For many, it designates the integrated approach or the corpus of computational methods employed to handle the vast amount of biological or medical data and investigate the complexity of the living. Although defining systems biology might be difficult, on the other hand its purpose is clear: systems biology, with its emerging subfields systems medicine and systems pharmacology, clearly aims at making sense of complex observations/experimental and clinical datasets to improve our understanding of diseases and their treatments without putting aside the context in which they appear and develop. In this short review, we aim to specifically focus on these new subfields with the new theoretical tools and approaches that were developed in the context of cancer. Systems pharmacology and medicine now give hope for major improvements in cancer therapy, making personalized medicine closer to reality. As we will see, the current challenge is to be able to improve the clinical practice according to the paradigm shift of systems sciences.

Entities:  

Keywords:  Big data; Drug development; Multi-scale approach; Personalized medicine; Precision medicine

Mesh:

Year:  2018        PMID: 29744615     DOI: 10.1007/s10441-018-9330-2

Source DB:  PubMed          Journal:  Acta Biotheor        ISSN: 0001-5342            Impact factor:   1.774


  8 in total

1.  Exploring the Mechanism of Icariin in Osteoporosis Based on a Network Pharmacology Strategy.

Authors:  Zhiyong Long; Jiamin Wu; Wang Xiang; Zhican Zeng; Ganpeng Yu; Jun Li
Journal:  Med Sci Monit       Date:  2020-11-24

2.  Targeting Cellular DNA Damage Responses in Cancer: An In Vitro-Calibrated Agent-Based Model Simulating Monolayer and Spheroid Treatment Responses to ATR-Inhibiting Drugs.

Authors:  Sara Hamis; James Yates; Mark A J Chaplain; Gibin G Powathil
Journal:  Bull Math Biol       Date:  2021-08-30       Impact factor: 1.758

Review 3.  From pharmacogenetics to pharmaco-omics: Milestones and future directions.

Authors:  Chiara Auwerx; Marie C Sadler; Alexandre Reymond; Zoltán Kutalik
Journal:  HGG Adv       Date:  2022-03-16

Review 4.  Personalized Medicine for Neuroblastoma: Moving from Static Genotypes to Dynamic Simulations of Drug Response.

Authors:  Jeremy Z R Han; Jordan F Hastings; Monica Phimmachanh; Dirk Fey; Walter Kolch; David R Croucher
Journal:  J Pers Med       Date:  2021-05-11

5.  Mathematical Modelling Based on In Vivo Imaging Suggests CD137-Stimulated Cytotoxic T Lymphocytes Exert Superior Tumour Control Due to an Enhanced Antimitotic Effect on Tumour Cells.

Authors:  Richard J Beck; Bettina Weigelin; Joost B Beltman
Journal:  Cancers (Basel)       Date:  2021-05-24       Impact factor: 6.639

6.  pH as a potential therapeutic target to improve temozolomide antitumor efficacy : A mechanistic modeling study.

Authors:  Angélique Stéphanou; Annabelle Ballesta
Journal:  Pharmacol Res Perspect       Date:  2019-01-28

7.  Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility.

Authors:  Flora T Musuamba; Ine Skottheim Rusten; Raphaëlle Lesage; Giulia Russo; Roberta Bursi; Luca Emili; Gaby Wangorsch; Efthymios Manolis; Kristin E Karlsson; Alexander Kulesza; Eulalie Courcelles; Jean-Pierre Boissel; Cécile F Rousseau; Emmanuelle M Voisin; Rossana Alessandrello; Nuno Curado; Enrico Dall'ara; Blanca Rodriguez; Francesco Pappalardo; Liesbet Geris
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-07-13

Review 8.  Can Systems Biology Advance Clinical Precision Oncology?

Authors:  Andrea Rocca; Boris N Kholodenko
Journal:  Cancers (Basel)       Date:  2021-12-16       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.